Psyence Biomedical Ltd. (PBM)
NASDAQ: PBMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 9, 10:13 AM ET
PBM stock chart
Technical analysisKey statistics
All statistics- EPS (TTM)
- -$12.56
- Dividend yield
- None
- 52-week range
- 1.92 – 150.78
- Day range
- 4.96 – 5.21
- Volume / Avg
- 9.64K / 94.85K
- Beta
- —
52-week range
PBM stock today
Psyence Biomedical (PBM) is trading at $4.99 on Oct 9, down 2.39% (-$0.1261), versus the S&P 500's 0.33% gain. Shares are 96.7% below their 52-week high of $150.78 and 160.1% above the 52-week low of $1.92, near the bottom of the past year's range. PBM is down 82.6% year to date, underperforming the S&P 500 (+13.5%). Over the past 12 months, the stock has lost 97.0%.
Psyence Biomedical has posted a net loss over the last twelve months (EPS of -$12.56), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Psyence Biomedical
Company profilePsyence Biomedical Ltd., an integrated biopharmaceutical company, focuses on the development of botanical psilocybin-based psychedelic medicines. Its lead product candidate is NPX-5, a botanical drug candidate that is in Phase IIb clinical study for the treatment of adjustment disorder in patients with cancer in a palliative care setting. The company is based in Toronto, Canada.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Jody Aufrichtig
- Headquarters
- Toronto, ON
- Employees
- 12
- Website
- psyencebiomed.com
Psyence Biomedical peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| NEUPNeuphoria Therapeutics Inc. | 3.32 | -0.89% | $17.97M | vs PBM |
| QNTMQuantum Biopharma Ltd. Class B Subordinate Voting Shares | 3.07 | -1.29% | $19.74M | vs PBM |
| NCELNewcelX Ltd. | 3.02 | -2.89% | $17.44M | vs PBM |
| AKTXAkari Therapeutics plc ADS | 8.67 | +2.12% | $19.81M | vs PBM |
| COCPCocrystal Pharma Inc. | 1.07 | -0.47% | $20.52M | vs PBM |
| RKTORocket One Inc. | 0.668 | +3.39% | $16.63M | vs PBM |
| RADXRadiopharm Theranostics Limited ADR | 1.14 | +2.25% | $16.56M | vs PBM |
| UPCUniverse Pharmaceuticals Inc. Class A | 4.12 | -0.72% | $20.70M | vs PBM |
Indexes, lists and sector
Psyence Biomedical stock FAQ
What is Psyence Biomedical's stock price today?
PBM last traded at $4.99 as of Oct 9, 10:13 AM EDT, down 2.39% on the day. Prices are delayed at least 15 minutes.
Does Psyence Biomedical pay a dividend?
No. Psyence Biomedical does not currently pay a regular cash dividend.
Who is Psyence Biomedical's CEO?
Mr. Jody Aufrichtig is the chief executive officer of Psyence Biomedical Ltd., which has about 12 employees.
Has PBM ever split its stock?
Yes. The most recent PBM stock split was a 16-for-100 split on Feb 2, 2026, one of 4 splits on record.
What is the PBM 52-week high?
The 52-week high for PBM is $150.78 and the 52-week low is $1.92. The stock is currently 96.7% below its high.